US Stock MarketDetailed Quotes

Lixte Biotechnology (LIXT)

Watchlist
  • 3.110
  • -0.130-4.01%
Close Mar 13 16:00 ET
  • 3.110
  • 0.0000.00%
Post 20:01 ET
27.07MMarket Cap-2.61P/E (TTM)

Lixte Biotechnology (LIXT) Key Financial Indicators

LIXT Earnings per Share (EPS)

According to the latest financial report of Lixte Biotechnology, the latest earnings per share (TTM) for the company is -0.33. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: USD

Quarterly

Loading...

LIXT Free Cash Flow (FCF)

Interested in knowing about Lixte Biotechnology's free cash flow? The latest report shows it as -926.75K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: USD

Quarterly

Loading...

LIXT Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lixte Biotechnology shows that the company's current ratio is 10.42, indicating healthy liquidity.

Currency: USD

Quarterly

Loading...

LIXT Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lixte Biotechnology, the quick ratio is 10.25, indicating that the company can meet its short-term debt obligations.

Currency: USD

Quarterly

Loading...

LIXT Return on Equity (ROE)

Want to learn more about the financial health of Lixte Biotechnology? The latest ROE figure is -134.92%, indicating that the company has stable profitability.

Currency: USD

Quarterly

Loading...

LIXT Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lixte Biotechnology, the total asset return on investment (ROA) is -61.33%.

Currency: USD

Quarterly

Loading...

LIXT Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lixte Biotechnology's latest financial report to see how their gross margin is doing - currently at --.

Currency: USD

Quarterly

Loading...

LIXT Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lixte Biotechnology, the net profit margin is -306.93%, which is a good sign for its profitability.

Currency: USD

Quarterly

Loading...

Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More